Johnson & Johnson ($JNJ) is scheduled to release earnings before Tuesday's open. The stock is widely owned and has been declining for the past six months. The stock could easily get going again if investors like the company's earnings. To help you prepare, here is what the Street is expecting:
Earnings Preview:
Johnson & Johnson is expected to report earnings of $1.56/share on $18.14 billion in revenue. Meanwhile, the so-called Whisper number is $1.59. The Whisper number is the Street's unofficial view on earnings.
Company Profile:
Johnson & Johnson, incorporated on November 10, 1887, is a holding company. The Company and its subsidiaries are engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Company's primary focus is on products related to human health and well-being. The Company's subsidiaries operate over 120 manufacturing facilities. The Company's research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom. The Company has over 250 operating companies, which conduct business around the world.
Consumer
The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The baby care category includes the JOHNSON'S line of products. Its oral care category includes the LISTERINE product line. Its brands in the skin care category include the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA and RoC product lines. The over-the-counter medicines category includes the family of TYLENOL acetaminophen products; SUDAFED cold, flu and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products, and the PEPCID line of heartburn products. Its brands in the women's health category outside of North America are STAYFREE and CAREFREE sanitary pad, and o.b. tampon brands. Its wound care brands include the BAND-AID Brand Adhesive Bandages and NEOSPORIN First Aid product lines. These products are marketed to the general public and sold both to retail outlets and distributors across the world.
Pharmaceutical
The Pharmaceutical segment is focused on over five therapeutic areas, including immunology (rheumatoid arthritis, inflammatory bowel disease, psoriasis and pulmonary diseases), infectious diseases (human immunodeficiency virus (HIV), hepatitis, respiratory infections, tuberculosis and vaccines), neuroscience (Alzheimer's disease, mood disorders and schizophrenia), oncology (prostate cancer, hematologic malignancies and lung cancer), and cardiovascular and metabolic diseases (thrombosis and diabetes).
Medical Devices
The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. The segment's products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. It includes orthopedic products, general surgery, biosurgical, endomechanical and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; diabetes care products, such as blood glucose monitoring and insulin delivery products, and disposable contact lenses.
Competitors:
The company is involved with many businesses and competes with many large companies such as: Clorox, Procter & Gamble, Dow Chemical, 3M, Colgate-Palmolive, DuPont, among others.
Pay Attention To How The Stock Reacts To The News:
From where I sit, the most important trait I look for during earnings season is how the market and a specific company reacts to the news.
